The Androgen Receptor Gene Polyglycine Repeat Polymorphism Is Associated With Memory Performance In Healthy Chinese Individuals

    March 2009 in “ Psychoneuroendocrinology
    Denes Kovacs, Evangelos Vassos, Xiehe Liu, Xiaochuan Sun, Junmei Hu, Gerome Breen, Peter Tompa, David Collier, Tao Li
    Image of study
    TLDR Certain gene variations are linked to better memory in healthy Chinese women.
    The study, involving 449 healthy Chinese participants (222 males and 227 females), explored the relationship between the androgen receptor gene (AR) polymorphisms—specifically the polyglutamine (CAG) and polyglycine (GGN) repeats—and memory performance. It was found that the CAG repeats had no significant impact on memory. In contrast, the GGN repeats were significantly associated with better performance in Immediate Logical Memory (p = 0.001) and Delayed Logical Memory (p = 0.022), with the association remaining significant for Immediate Logical Memory after permutation corrections (p = 0.013). This link was only evident in females (p = 0.002 for Immediate and p = 0.014 for Delayed Logical Memory), suggesting that the GGN repeat length in the AR gene may play a role in modulating memory function in women. These findings could be relevant for understanding memory-related conditions such as schizophrenia and Alzheimer's disease, although the study's focus on a healthy, Chinese cohort may limit the wider applicability of the results. Future research with larger and more diverse populations is recommended to further investigate the genetic basis of cognitive functions.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community Hair loss causes are still a myth.

      in Chat  17 upvotes 3 years ago
      The conversation discusses the complexity of hair loss causes, suggesting that DHT sensitivity alone doesn't fully explain it. Treatments mentioned include finasteride and dutasteride.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  124 upvotes 1 year ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

    Similar Research

    5 / 1000+ results